Showing results (741-750 of 787) with videos related to

Sort By:
Pageof 79
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapyYingye Zheng, Dionyssios Katsaros, Shannon J C Shan, et al.
Clinical Chemistry and Laboratory Medicine|May 17, 2018
Exploring the potential of mucin 13 (MUC13) as a biomarker for carcinomas and other diseasesPanagiota S Filippou, Annie H Ren, Dimitrios Korbakis, et al.
Research Square|December 11, 2023
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodiesMiyo K Chatanaka, Lisa M Avery, Maria D Pasic, et al.
The American Journal of Clinical Nutrition|March 13, 1999
Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trialD J Jenkins, C W Kendall, E Vidgen, et al.
Cancer Research|November 3, 2001
Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic markerG M Yousef, L G Kyriakopoulou, A Scorilas, et al.
Diagnosis (Berlin, Germany)|February 14, 2023
Quantitation of neurofilament light chain protein in serum and cerebrospinal fluid from patients with multiple sclerosis using the MSD R-PLEX NfL assayAntigona Ulndreaj, Dorsa Sohaei, Simon Thebault, et al.
Frontiers in Neurology|January 6, 2022
Putative Concussion Biomarkers Identified in Adolescent Male Athletes Using Targeted Plasma ProteomicsMichael R Miller, Michael Robinson, Lisa Fischer, et al.
Biological Chemistry|April 17, 2012
Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patientsLina Seiz, Julia Dorn, Matthias Kotzsch, et al.
British Journal of Cancer|January 26, 2006
Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal statusF Fritzsche, T Gansukh, C A Borgoño, et al.
Clinical Chemistry and Laboratory Medicine|April 27, 2022
Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigensAntigona Ulndreaj, Mingyue Wang, Salvia Misaghian, et al.
Pageof 79